Peroxisome proliferator-activated receptors as molecular targets for drug therapy

Journal of Association of Physicians of India

Volumn 51, Issue JAN, 2003, Pages 49-52

  Sridhar, G R ^a  

^a Endocrine and Diabetes Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; TRANSCRIPTION FACTOR;

ARTERIOSCLEROSIS; ARTICLE; CLASSIFICATION; DRUG EFFECT; DRUG THERAPY; HUMAN; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY; HUMANS; MOLECULAR BIOLOGY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0038179867     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Lee KC, Kraus WL. Nuclear receptors, coactivators and chromatin: new approaches, new insights. Trends Endocrinol Metab 2001;12:191-7.
2. Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 2001;79:30-47.
3. Rosen ED, Spiegelman BM. PPAR (gamma): a nuclear receptor of metabolism, differentiation and cell growth. J Biol Chem 2001;276:37731-4.
4. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Med 2001;7:48-52.
5. Kliewer SA, Xu HE, Lambert MH, Willison TM. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Pros Horm Res 2001;56:239-63.
6. Girard J. Mechanisms of action of thiazolidinediones. Diabetes Metab 2001;27:271-8.
7. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall. Z Kardiol 2001;90(Suppl3):125-32.
8. Balasubramanyam M, Mohan V. Current concepts of PPAR gamma signaling in diabetes mellitus. Current Sci 2000;79:1440-6.
9. Foyt HL, Ghazzi MN, Hanley RM, Saltiel AR, Whitcomb RW. Thiazolidinediones. In Le Roith, Taylor SI, Olefsky JM, editors. Diabetes mellitus. Philadelphia Lippincott, 2000;788-97.
10. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-action in humans. Diabetes 2001;50:2199-202.
11. Plutzky J. Peroxisome proliferator-activated receptors in endothelial cell biology. Curr Opin Lipidol 2001;12:511-8.
12. Ricote M, Glass CK. New roles for PPARs in cholesterol homeostasis. Trends Pharmacol Sci 2001;22:441-3.
13. Moore KJ, Rosen ED, Fitzgerald ML, et al. The role of PPAR gamma in macrophage differentiation and cholesterol uptake. Nature Med 2001;7:41-7.
14. Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome prolifertor-activated receptor alpha (PPAR alpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med 2001;79:198-204.
15. Evans D, de Heer J, Hagemann C, et al. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator-activated receptor gamma (PPAR gamma) gene and type 2 diabetes. Exp Clin Endocrinol Diabetes 2001;109:151-4.
16. Douglas JA, Erdos MR, Watanabe RM, et al. The peroxisome proliferator-activated receptor-gamma 2 Prol 121 a variant: association with type 2 diabetes and trait differences. Diabetes 2001;50:986-90.
17. Fritsche A, Madaus A, Tschritter O, et al. Polymorphism of pro 121a in peroxisome proliferator-activated receptor gamma 2 (PPARgamma2): beta cell function and insulin sensitivity. Disch Med Wochenschr 2001;126:580-4.
18. Millo MG, Rouault C, Poulain P, et al. PPAR-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 2001;50:2809-14.
19. Codner E, Loviscach M, Ciaraldi TP, et al. Retinoid X receptor expression in skeletal muscle of non-diabetic, obese and type 2 diabetic individuals. Metabolism 2001;50:830-4.
20. Cha BS, Ciaraldi TP, Carter L, et al. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 2001;44:444-52.
21. Hsueh WC, Cole SA, Shuldiner AR, et al. Interactions between variants in the beta3-adrenergic receptor and peroxisome prolifertor-activated receptor-gamma2 genes and obesity. Diabetes Care 2001;24:672-7.
22. Sridhar GR. Impact of human genome project on medical practice. J Assoc Physicians India 2001;49:905-8.
23. Sridhar GR. Adiposity and diabetes:biochemical link. Current Sci 2001;81:1410-1.